Viewing Study NCT00328120


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2026-01-24 @ 7:59 AM
Study NCT ID: NCT00328120
Status: COMPLETED
Last Update Posted: 2010-11-17
First Post: 2006-05-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Faslodex 500mg Multiple Dose Tolerability Study in BC Patients
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced breast cancer View
None Faslodex View